Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment.

[1]  J. Koskinas,et al.  Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitis , 2018, Annals of gastroenterology.

[2]  G. Dalekos,et al.  Prompt initiation of high‐dose i.v. corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis , 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  G. Dalekos,et al.  Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis , 2018, Case reports in hepatology.

[4]  E. Santos,et al.  Concurrent autoimmune hepatitis in multiple sclerosis , 2018, Multiple sclerosis.

[5]  S. Vukusic,et al.  Methylprednisolone liver toxicity: A new case and a French regional pharmacovigilance survey. , 2017, Clinics and research in hepatology and gastroenterology.

[6]  M. Heneghan,et al.  Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long‐term outcomes , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[7]  M. Manns,et al.  Cutting edge issues in autoimmune hepatitis. , 2016, Journal of autoimmunity.

[8]  A. Quaas,et al.  Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis. , 2016, Journal of hepatology.

[9]  S. Haralambous,et al.  IFN-β differentially regulates the function of T cell subsets in MS and EAE. , 2016, Cytokine & growth factor reviews.

[10]  G. Hirschfield,et al.  Editorial: autoimmune hepatitis – identifying options for treatment , 2016, Alimentary pharmacology & therapeutics.

[11]  G. Dalekos,et al.  Editorial: autoimmune hepatitis – identifying options for treatment. Authors’ reply , 2016, Alimentary Pharmacology and Therapeutics.

[12]  C. Triantos,et al.  Spontaneous Cirrhosis Regression in an IFN-beta-induced AIH-like Syndrome Following Drug Withdrawal: Art of Facts or Artifacts? , 2016, European Journal of Case Reports in Internal Medicine.

[13]  F. Trimarchi,et al.  Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy , 2016, Endocrine.

[14]  E. Rigopoulou,et al.  A real‐world study focused on the long‐term efficacy of mycophenolate mofetil as first‐line treatment of autoimmune hepatitis , 2016, Alimentary pharmacology & therapeutics.

[15]  D. Vergani,et al.  In autoimmune hepatitis type 1 or the autoimmune hepatitis–sclerosing cholangitis variant defective regulatory T‐cell responsiveness to IL‐2 results in low IL‐10 production and impaired suppression , 2015, Hepatology.

[16]  M. Manns,et al.  Autoimmune hepatitis--Update 2015. , 2015, Journal of hepatology.

[17]  A. Gadano,et al.  Interferon beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: report of two cases and review of the literature. , 2015, Annals of hepatology.

[18]  D. Bogdanos,et al.  Anti‐SLA/LP alone or in combination with anti‐Ro52 and fine specificity of anti‐Ro52 antibodies in patients with autoimmune hepatitis , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[19]  G. Dalekos,et al.  Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. , 2015, World journal of gastroenterology.

[20]  A. Granito,et al.  Review article: autoimmune hepatitis – current management and challenges , 2013, Alimentary pharmacology & therapeutics.

[21]  G. Dalekos,et al.  Use of TNFα antagonists in refractory AIH: revealing the unforeseen. , 2013, Journal of hepatology.

[22]  A. Czaja.  Acute and Acute Severe (Fulminant) Autoimmune Hepatitis , 2013, Digestive Diseases and Sciences.

[23]  D. Sautereau,et al.  Acute liver toxicity due to methylprednisolone: consider this diagnosis in the context of autoimmunity. , 2013, Clinics and research in hepatology and gastroenterology.

[24]  R. Andrade,et al.  The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug‐induced liver injury , 2011, Hepatology.

[25]  E. Rigopoulou,et al.  Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients. , 2011, Journal of hepatology.

[26]  O. Yokosuka,et al.  Autoimmune fulminant hepatic failure in chronic hepatitis C during Peg-interferon-alpha 2b plus ribavirin treatment showing histological heterogeneity. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[27]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[28]  William M. Lee,et al.  Autoimmune acute liver failure: Proposed clinical and histological criteria , 2011, Hepatology.

[29]  E. Rigopoulou,et al.  Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score? , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[30]  D. Gorard,et al.  Autoimmune hepatitis triggered by nitrofurantoin: a case series , 2010, Journal of medical case reports.

[31]  J. Talwalkar,et al.  Drug‐induced autoimmune hepatitis: Clinical characteristics and prognosis , 2010, Hepatology.

[32]  P. Meroni,et al.  Type I interferon therapy and its role in autoimmunity , 2010, Autoimmunity.

[33]  S. Dhib-jalbut,et al.  Interferon-β mechanisms of action in multiple sclerosis , 2010, Neurology.

[34]  A. Irisawa,et al.  Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: a case report. , 2008, World journal of gastroenterology.

[35]  K. Boberg,et al.  Simplified criteria for the diagnosis of autoimmune hepatitis , 2008, Hepatology.

[36]  P. Oschmann,et al.  Autoimmune hepatitis after high-dose intravenous methylprednisolone pulse in RR-MS , 2007 .

[37]  P. Vermersch,et al.  Autoimmune hepatitis and multiple sclerosis: a coincidental association? , 2005, Multiple sclerosis.

[38]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[39]  E. Rigopoulou,et al.  Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease , 2004, Journal of autoimmune diseases.

[40]  M. Manns,et al.  Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. , 2004, Journal of hepatology.

[41]  G. Cooper,et al.  The epidemiology of autoimmune diseases. , 2003, Autoimmunity reviews.

[42]  A. Duchini.  Autoimmune hepatitis and interferon beta-1a for multiple sclerosis , 2002, American Journal of Gastroenterology.

[43]  A. Ghezzi,et al.  Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases? , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[44]  A. Ghezzi,et al.  Liver and thyroid function and autoimmunity during interferon-β1b treatment for MS , 2001, Neurology.

[45]  Richard A. C. Hughes,et al.  PRISMS-4: Long-term efficacy of interferon-&bgr;-1a in relapsing MS , 2001, Neurology.

[46]  D. Bever,et al.  PRISMS-4: Long-term efficacy of interferon-β-1a in relapsing MS , 2001, Neurology.

[47]  J. Lord,et al.  IFN-α and IFN-β: a link between immune memory and chronic inflammation , 2000 .

[48]  M. Manns,et al.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.

[49]  H. Wedemeyer,et al.  Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment. , 1999, Journal of hepatology.

[50]  K. Ishak,et al.  Histological grading and staging of chronic hepatitis. , 1995 .

[51]  J. Drenth.  EASL Clinical Practice Guidelines: Autoimmune hepatitis. , 2015, Journal of hepatology.

[52]  E. Rigopoulou,et al.  Autoimmune hepatitis in patients with chronic HBV and HCV infections: patterns of clinical characteristics, disease progression and outcome. , 2013, Annals of hepatology.

[53]  G. Francis,et al.  Hepatic Reactions During Treatment of Multiple Sclerosis with Interferon-β-1a , 2003 .